Environmental Triggers of Psoriasis
The transition from Psoriasis to PsA
Psoriatic Arthritis Screening
How to improve early diagnosis of PsA:
Imaging in PsA
Comorbidities, Cardiovascular disease, diet and their role in treatment decision
Obesity e GLP-1R and GLP-1R/GIPR agonists in PsA
Impact of sex and gender in PsA on diagnosis, management and treatment
Which Psoriasis Biologic for Which Patient?
Update on D2T and C2M
Dual therapy uses and safety
Pipeline: new iIL-17, oral iIL-23
Potential for cell therapy approaches